3/27
09:00 pm
lenz
Why Lenz Therapeutics Stock Plummeted by Almost 20% This Week [Yahoo! Finance]
Neutral
Report
Why Lenz Therapeutics Stock Plummeted by Almost 20% This Week [Yahoo! Finance]
3/27
06:41 pm
lenz
LENZ Therapeutics: Q4 Results Highlight A Worrying Lack Of Market Demand (Rating Downgrade) [Seeking Alpha]
Low
Report
LENZ Therapeutics: Q4 Results Highlight A Worrying Lack Of Market Demand (Rating Downgrade) [Seeking Alpha]
3/26
11:52 am
lenz
LENZ Therapeutics (LENZ) had its price target lowered by Citigroup Inc. from $52.00 to $26.00. They now have a "buy" rating on the stock.
Medium
Report
LENZ Therapeutics (LENZ) had its price target lowered by Citigroup Inc. from $52.00 to $26.00. They now have a "buy" rating on the stock.
3/25
09:28 am
lenz
LENZ Therapeutics (LENZ) had its price target lowered by Bank of America Corporation from $35.00 to $29.00. They now have a "buy" rating on the stock.
Low
Report
LENZ Therapeutics (LENZ) had its price target lowered by Bank of America Corporation from $35.00 to $29.00. They now have a "buy" rating on the stock.
3/24
03:56 pm
lenz
LENZ Therapeutics, Inc. (LENZ) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
LENZ Therapeutics, Inc. (LENZ) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/24
03:21 pm
lenz
LENZ Therapeutics Inc (LENZ) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]
Medium
Report
LENZ Therapeutics Inc (LENZ) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]
3/24
10:43 am
lenz
Why Lenz Therapeutics Stock Crashed Today [Yahoo! Finance]
Medium
Report
Why Lenz Therapeutics Stock Crashed Today [Yahoo! Finance]
3/24
10:22 am
lenz
LENZ Therapeutics, Inc. (LENZ) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
Medium
Report
LENZ Therapeutics, Inc. (LENZ) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
3/24
08:14 am
lenz
LENZ Therapeutics GAAP EPS of -$1.16 misses by $0.26, revenue of $1.59M misses by $1.5M [Seeking Alpha]
High
Report
LENZ Therapeutics GAAP EPS of -$1.16 misses by $0.26, revenue of $1.59M misses by $1.5M [Seeking Alpha]
3/24
08:00 am
lenz
LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
High
Report
LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
3/21
01:31 am
lenz
Low
Report
3/17
08:00 am
lenz
LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026
Medium
Report
LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026
3/10
12:06 pm
lenz
LENZ Therapeutics (LENZ) had its "outperform" rating reaffirmed by William Blair.
Low
Report
LENZ Therapeutics (LENZ) had its "outperform" rating reaffirmed by William Blair.
3/10
08:00 am
lenz
LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia
Medium
Report
LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia
3/1
01:10 am
lenz
Medium
Report
2/23
08:13 am
lenz
LENZ Therapeutics to Present at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
LENZ Therapeutics to Present at Upcoming Investor Conferences [Yahoo! Finance]
2/23
08:00 am
lenz
LENZ Therapeutics to Present at Upcoming Investor Conferences
Low
Report
LENZ Therapeutics to Present at Upcoming Investor Conferences
2/21
02:04 am
lenz
LENZ Therapeutics (NASDAQ:LENZ) was downgraded by analysts at
Wall Stree
Medium
Report
LENZ Therapeutics (NASDAQ:LENZ) was downgraded by analysts at
Wall Stree
1/22
10:00 am
lenz
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
High
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
1/20
04:37 pm
lenz
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
1/15
10:00 am
lenz
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
1/14
09:12 am
lenz
LENZ Therapeutics and Sarah Jessica Parker announce the launch of "Make it VIZZable", the VIZZ consumer campaign [Yahoo! Finance]
High
Report
LENZ Therapeutics and Sarah Jessica Parker announce the launch of "Make it VIZZable", the VIZZ consumer campaign [Yahoo! Finance]
1/14
08:30 am
lenz
LENZ Therapeutics and Sarah Jessica Parker announce the launch of "Make it VIZZable", the VIZZ consumer campaign
High
Report
LENZ Therapeutics and Sarah Jessica Parker announce the launch of "Make it VIZZable", the VIZZ consumer campaign
1/14
08:30 am
lenz
LENZ Therapeutics and Sarah Jessica Parker announce the launch of “Make it VIZZable”, the VIZZ consumer campaign
High
Report
LENZ Therapeutics and Sarah Jessica Parker announce the launch of “Make it VIZZable”, the VIZZ consumer campaign
1/13
04:39 pm
lenz
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
High
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ